Enhanced oral bioavailability of valsartan using a polymer-based supersaturable self-microemulsifying drug delivery system

References

• BegSSwainSSinghHPPatraCNRaoMBDevelopment, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriersAAPS PharmSciTech20121341416142723070560
   PubMed Web of Science ®Google Scholar
• DixitARRajputSJPatelSGPreparation and bioavailability assessment of SMEDDS containing valsartanAAPS PharmSciTech201011131432120182825
   PubMed Web of Science ®Google Scholar
• YanYDSungJHKimKKNovel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changesInt J Pharm2012422120221022085435
   PubMedGoogle Scholar
• BaekIHKimJSHaESOral absorption of a valsartan-loaded spray-dried emulsion based on hydroxypropylmethyl celluloseInt J Biol Macromol20146922222824879921
   PubMed Web of Science ®Google Scholar
• KimMSBaekIHFabrication and evaluation of valsartan-polymer-surfactant composite nanoparticles by using the supercritical antisolvent processInt J Nanomedicine2014915167517625404856
   PubMedGoogle Scholar
• MaQSunHCheEUniform nano-sized valsartan for dissolution and bioavailability enhancement: influence of particle size and crystalline stateInt J Pharm20134411758123266761
   PubMedGoogle Scholar
• DangrePVGilhotraRMDholeSNFormulation and development of solid self micro-emulsifying drug delivery system (S-SMEDDS) containing chlorthalidone for improvement of dissolutionJ Pharm Invest2016467633644
   Google Scholar
• PorterCJCharmanWNLipid-based formulations for oral administration: opportunities for bioavailability enhancement and lipoprotein targeting of lipophilic drugsJ Recept Signal Transduct Res2001212–321525711757684
   PubMed Web of Science ®Google Scholar
• RaoBPBabyBDurgaprasadYFormulation and evaluation of SMEDDS with Capmul MCM for enhanced dissolution rate of valsartanRGUHS J Pharm Sci2013323340
   Google Scholar
• PoudelBKMarasiniNTranTHChoiHGYongCSKimJOFormulation, characterization and optimization of valsartan self-microemulsifying drug delivery system using statistical design of experimentChem Pharm Bull201260111409141823124565
   PubMed Web of Science ®Google Scholar
• ZhaoKYuanYWangHLiPBaoZLiYPreparation and evaluation of valsartan by a novel semi-solid self-microemulsifying delivery system using Gelucire 44/14Drug Dev Ind Pharm201642101545155226857923
   PubMed Web of Science ®Google Scholar
• LeeDHYeomDWSongYSImproved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS)Int J Pharm2015478134134725437113
   PubMed Web of Science ®Google Scholar
• SongWHParkJHYeomDWEnhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulationArch Pharm Res2013361697823325487
   PubMed Web of Science ®Google Scholar
• GaoPRushBDPfundWPDevelopment of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailabilityJ Pharm Sci200392122386239814603484
   PubMed Web of Science ®Google Scholar
• BevernageJBrouwersJBrewsterMEAugustijnsPEvaluation of gastrointestinal drug supersaturation and precipitation: strategies and issuesInt J Pharm20134531253523194883
   PubMed Web of Science ®Google Scholar
• ChauhanHHui-GuCAtefECorrelating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersionsJ Pharm Sci201310261924193523580406
   PubMed Web of Science ®Google Scholar
• XuSDaiWGDrug precipitation inhibitors in supersaturable formulationsInt J Pharm20134531364323680727
   PubMed Web of Science ®Google Scholar
• CaoQRLiuYXuWJLeeBJYangMCuiJHEnhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating techniqueInt J Pharm2012434132533322688251
   PubMedGoogle Scholar
• YeomDWSongYSKimSRDevelopment and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture designInt J Nanomedicine2015103865387726089663
   PubMed Web of Science ®Google Scholar
• KhanKAThe concept of dissolution efficiencyJ Pharm Pharmacol19752714849235616
   PubMed Web of Science ®Google Scholar
• SongWHYeomDWLeeDHIn situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery systemArch Pharm Res201437562663523852645
   PubMed Web of Science ®Google Scholar
• KojimaTHigashiKSuzukiTTomonoKMoribeKYamamotoKStabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT® EPOPharm Res201229102777279122219167
   PubMedGoogle Scholar
• ChenZQLiuYZhaoJHWangLFengNPImproved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery systemInt J Nanomedicine2012711115112522403491
   PubMedGoogle Scholar
• ZhangNZhangWJinYQuanDQStudies on preparation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation and relative bioavailability in beagle dogsPharm Dev Technol201116441542120433250
   PubMed Web of Science ®Google Scholar
• GaoPGuytonMEHuangTBauerJMStefanskiKJLuQEnhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulationsDrug Dev Ind Pharm200430222122915089057
   PubMed Web of Science ®Google Scholar
• DashRNMohammedHHumairaTDesign, optimization, and evaluation of ezetimibe solid supersaturatable self-nanoemulsifying drug delivery for enhanced solubility and dissolutionJ Pharm Invest2016462153168
   Google Scholar
• ChutimaworapanSRitthidejGCYonemochiEOguchiTYamamotoKEffect of water-soluble carriers on dissolution characteristics of nifedipine solid dispersionsDrug Dev Ind Pharm200026111141115011068687
   PubMed Web of Science ®Google Scholar
• SethiaSSquillanteEPhysicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation methodJ Pharm Sci20029191948195712210042
   PubMed Web of Science ®Google Scholar
• DaiWGDongLCLiSDengZCombination of Pluronic/Vitamin E TPGS as a potential inhibitor of drug precipitationInt J Pharm20083551313718299178
   PubMedGoogle Scholar
• MaibaumLDinnerARChandlerDMicelle formation and the hydrophobic effectJ Phys Chem B20041082167786781
   Web of Science ®Google Scholar
• KimSGuptaBMoonCEmploying an optimized spray-drying process to produce ezetimibe tablets with an improved dissolution profileJ Pharm Invest2016466583592
   Google Scholar
• AtiklerUDemirHTokatlıFTıhmınlıoğluFBalköseDÜlküSOptimisation of the effect of colemanite as a new synergistic agent in an intumescent systemPolym Degrad Stab200691715631570
   Web of Science ®Google Scholar
• ZuYZhangYZhaoXZhangQLiuYJiangROptimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM)Int J Nanomedicine2009432133320054435
   PubMed Web of Science ®Google Scholar
• KimMSYeomDWKimSRDevelopment of a chitosan based double layer-coated tablet as a platform for colon-specific drug deliveryDrug Des Devel Ther2017114557
   PubMed Web of Science ®Google Scholar
• BezerraMASantelliREOliveiraEPVillarLSEscaleiraLAResponse surface methodology (RSM) as a tool for optimization in analytical chemistryTalanta200876596597718761143
   PubMed Web of Science ®Google Scholar
• DabbasRMFowlerJWRollierDAMccarvilleDMultiple response optimization using mixture-designed experiments and desirability functions in semiconductor schedulingInt J Prod Res2003415939961
   Web of Science ®Google Scholar
• FleschGMüllerPLloydPAbsolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in manEur J Clin Pharmacol19975221151209174680
   PubMed Web of Science ®Google Scholar
• DressmanJBReppasCIn vitro–in vivo correlations for lipophilic, poorly water-soluble drugsEur J Pharm Sci200011Suppl 2S73S8011033429
   PubMed Web of Science ®Google Scholar
• GosangariSDyakonovTEnhanced dissolution performance of curcumin with the use of supersaturatable formulationsPharm Dev Technol201318247548022881446
   PubMed Web of Science ®Google Scholar
• YangSGBiowaiver extension potential and IVIVC for BCS Class II drugs by formulation design: case study for cyclosporine self-microemulsifying formulationArch Pharm Res201033111835184221116787
   PubMed Web of Science ®Google Scholar
• EmamiJIn vitro–in vivo correlation: from theory to applicationsJ Pharm Pharm Sci20069216918916959187
   PubMed Web of Science ®Google Scholar
• KimMSHaESChooGHBaekIHPreparation and in vivo evaluation of a dutasteride-loaded solid-supersaturatable self-microemulsifying drug delivery systemInt J Mol Sci2015165108211083325984604
   PubMedGoogle Scholar
• AmidonGLLennernäsHShahVPCrisonJRA theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailabilityPharm Res19951234134207617530
   PubMed Web of Science ®Google Scholar